GHCM
WVE icon

Glen Harbor Capital Management’s Wave Life Sciences WVE Stock Holding History

Glen Harbor Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,260
Closed -$33K – 1352
2019
Q2 		$33K Buy
1,260
+252
+25% +$7.07K ﹤0.01% 1277
2019
Q1 		$39K Buy
1,008
+252
+33% +$10.2K ﹤0.01% 1239
2018
Q4 		$32K Buy
+756
New +$33.6K ﹤0.01% 1207
2018
Q3 		– Sell
-588
Closed -$22K – 1294
2018
Q2 		$22K Buy
+588
New +$25.3K ﹤0.01% 1251

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Glen Harbor Capital Management's WVE Position: Q3 2019 in Review

Glen Harbor Capital Management sold out of Wave Life Sciences (WVE) in Q3 2019, closing a stake of 1,260 shares — an estimated $33K sold.

Glen Harbor Capital Management first reported a position in WVE in Q2 2018 and held it in 4 quarters. The position peaked at $39K in Q1 2019. 88 funds tracked by Wall St. Rank hold WVE as of Q3 2019.

  • Glen Harbor Capital Management reported no remaining Wave Life Sciences position as of Q3 2019 after selling out during the quarter.
  • Glen Harbor Capital Management sold 1,260 Wave Life Sciences shares in Q3 2019, an estimated $33K.
  • Glen Harbor Capital Management first reported a position in Wave Life Sciences in Q2 2018 and held it in 4 quarters.
  • Glen Harbor Capital Management's Wave Life Sciences position peaked at $39K in Q1 2019.
  • 88 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.